Genome-scale modelling and stable isotope tracing reveal dynamic metabolic reprogramming in a human cardiac hypertrophy model
Catherine K Takemura-James, Katarzyna Kmiotek-Caller, Ravi A Kumar, Eliano dos Santos, Rafael R Oexner, Christina M Reumiller, Sharwari Verma, Ella Bauwens, Elisavet Kiaitsi, Celio X C Santos, Katrin Streckfuss-Boemeke, Ajay M ShahiD, Anna ZoccaratoiD
Abstract
Pathological cardiac hypertrophy is associated with metabolic remodelling; however the temporal dynamics of this remodelling remain poorly defined in human cardiomyocyte systems. Here, we combined transcriptomic profiling, genome-scale metabolic modelling and stable isotope-resolved metabolomics (SIRM) to map the metabolic consequences of endothelin-1 (ET-1) stimulation in human iPSC-derived cardiomyocytes (hiPSC-CMs). Integration of RNA sequencing data obtained after 8 and 48 hours of ET-1 treatment with the Human2.0 genome-scale metabolic model predicted time-dependent remodelling, characterised by progressive increases in glycolytic flux, enhanced glucose carbon entry into the TCA cycle, and a decrease in fatty acid {beta}-oxidation. Computational flux predictions were independently confirmed by extracellular flux analysis and 13C-substrate tracing, with concordance between modelled and measured fluxes. Extracellular flux analysis showed increased glycolytic capacity and mitochondrial respiration after 48 hours, with greater sensitivity to inhibition of mitochondrial pyruvate transport. Glucose tracing revealed increased 13C enrichment of glycolytic, pentose phosphate pathway, serine-glycine and TCA cycle metabolites, consistent with altered glucose-derived carbon allocation. Increased m+3 labelling of selected TCA-related metabolites was compatible with pyruvate anaplerosis, although pathway-specific fluxes were not resolved. In three-dimensional engineered heart tissue (EHTs) treated with ET-1 for 7 days, increased hypertrophic marker expression was accompanied by a blunted inotropic response, and metabolomics showed similar changes in metabolite abundance and glucose-derived labelling to 2D cultures. These findings support hiPSC-CMs and EHTs as complementary platforms for studying early metabolic remodelling in pathological cardiac hypertrophy and provide an integrated framework linking model predictions to functional and isotope-tracing measurements.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cells
G. Emanuelli, A. Zoccarato, … A. Shah·bioRxiv·Sep 28, 2020
- Transcriptomics reveal stretched human pluripotent stem cell-derived cardiomyocytes as an advantageous hypertrophy model
L. Pohjolainen, H. Ruskoaho, V. Talman·bioRxiv·Dec 13, 2021
- Multiomics-based assessment of 2D and 3D human iPSC-cardiomyocyte models of insulin resistance demonstrate metabolic and contractile dysfunction that recapitulates diabetic cardiomyopathy.
Ryan D. Carter, Ujang Purnama, … Carolyn A. Carr·bioRxiv·Nov 20, 2024
- Hierarchical control of cardiomyocyte maturation and ischaemia sensitivity by metabolic culture conditions
Yuanzhao Cao, Chris Siu Yeung Chow, … Nathan J. Palpant·bioRxiv·Mar 15, 2026
- Molecular Rewiring in TNNT2-Linked Hypertrophic Cardiomyopathy hiPSC-Derived Cardiomyocytes upon Metabolic Maturation
Homa Hamledari, Farah Jayousi, … Sheila S. Teves·bioRxiv·Sep 14, 2025
- Hepatic Ketogenesis Attenuates Cardiac Hypertrophy via Metabolic Reprogramming
Toshihiro Yamada, Kei Morikawa, … Yuichiro Arima·bioRxiv·Feb 2, 2026